甲状腺乳头状癌组织中E74样ETS转录因子3表达上调的临床意义OA
Clinical Significance of Upregulated Expression of E74-like ETS Transcription Factor 3 in Papillary Thyroid Carcinoma Tissue
目的 分析E74 样ETS转录因子 3(ELF3)在甲状腺乳头状癌(PTC)中的异常表达及临床意义.方法 收集广西医科大学第一附属医院 9 例PTC样本,PTC组织作为实验组,对应的癌旁组织作为对照组;从桂林泛谱生物技术有限公司购买 4 个组织芯片(THC481、THC961、THC1021 和THC1501),其中包括 45 个非癌甲状腺组织和 136 个PTC组织,采用免疫组化检测ELF3 蛋白表达水平.基于GEO、TCGA和GTEx数据库中与PTC相关的基因芯片和RNA-seq数据评估ELF3 mRNA表达,利用cBioPortal数据库查询PTC中ELF3 的遗传改变,通过结合ELF3 的靶基因、PTC中上调的差异表达基因和ELF3 共表达基因,进行富集分析以及蛋白-蛋白相互作用(PPI)分析,探索ELF3 在PTC中可能的信号通路和靶基因.结果 免疫组化结果显示,PTC组织(n=145)中ELF3 蛋白表达显著高于癌旁组织(n=54)(P<0.001).与蛋白质水平一致,与癌旁组织(n=778)相比,PTC组织(n=1136)中的ELF3 mRNA表达上调,标准均数差为 0.44(95%CI:0.25~0.62,P=0.019),受试者工作特征曲线下面积为 0.68(95%CI:0.64~0.72).来自cBioPortal的数据表明,6%的PTC病例存在ELF3 基因改变.富集分析显示ELF3 候选靶基因可能涉及信号转导、细胞黏着、调亡过程等生物学过程,参与构成细胞质膜、膜、细胞溶质等细胞成分,并发挥与蛋白结合等分子功能.此外,观察到ELF3 可能与细胞因子-细胞因子相互作用以及MAPK信号通路有关.通过构建PPI网络并结合 ChIP-seq数据,获得 2 个ELF3 潜在靶基因,即FN1 和ICAM1,且ELF3 的表达与FN1 和ICAM1 呈较强的正相关性.结论 ELF3 的上调可能在PTC的发生发展中起重要作用,这些作用可能通过ELF3 调控下游靶基因FN1 和ICAM1 来完成.
Objective To analyze the abnormal expression and clinical significance of E74-like ETS transcription factor 3(ELF3)in papillary thyroid carcinoma(PTC).Methods Nine PTC samples were collected from the First Affiliated Hospital of Guangxi Medical University.The PTC tissues were used as the experimental group,and the corresponding adjacent tissues were used as the control group.Four tissue chips(THC481,THC961,THC1021 and THC1501)were purchased from Guilin Fanpu Biotech,Inc.,including 45 non-cancerous thyroid tissues and 136 PTC tissues.The expression level of ELF3 protein was detected by immunohistochemistry.The expression of ELF3 mRNA was evaluated based on PTC-related gene chips and RNA-seq data in GEO,TCGA and GTEx databases.The cBioPortal database was used to query the genetic changes of ELF3 in PTC.By combining the target genes of ELF3,the up-regulated differentially expressed genes in PTC and the co-expressed genes of ELF3,enrichment analysis and protein-protein interaction(PPI)analysis were performed to explore the possible signaling pathways and target genes of ELF3 in PTC.Results Immunohistochemistry results showed that ELF3 protein expression in PTC tissues(n=145)was significantly higher than that in adjacent non-cancerous tissues(n=54)(P<0.001).Consistent with the protein level,ELF3 mRNA expression was upregulated in PTC tissues(n=1136)compared with adjacent non-cancerous tissues(n=778),with a standardized mean difference of 0.44(95%CI:0.25-0.62,P=0.019),and the area under the receiver operating characteristic curve was 0.68(95%CI:0.64-0.72).Data from cBioPortal indicated that ELF3 gene alterations were present in 6%of PTC cases.Enrichment analysis revealed that the candidate target genes of ELF3 might be involved in biological processes such as signal transduction,cell adhesion,and apoptotic process,participate in cellular components including plasma membrane,membrane,and cytosol,and exert molecular functions such as protein binding.Furthermore,it was observed that ELF3 might be associated with cytokine-cytokine interactions and the MAPK signaling pathway.By constructing a PPI network combined with ChIP-seq data,two potential target genes of ELF3,namely FN1 and ICAM1,were identified,and the expression of ELF3 showed a strong positive correlation with FN1 and ICAM1.Conclusion The up-regulation of ELF3 may play an important role in the occurrence and development of PTC,which may be achieved by ELF3 regulating downstream target genes FN1 and ICAM1.
李柳艳;李建棣;庞玉艳;陈罡;危丹明
广西医科大学第一附属医院病理科,广西 南宁 530021广西医科大学第一附属医院病理科,广西 南宁 530021广西医科大学第一附属医院病理科,广西 南宁 530021广西医科大学第一附属医院病理科,广西 南宁 530021广西医科大学第一附属医院病理科,广西 南宁 530021
医药卫生
甲状腺乳头状癌ELF3免疫组织化学RNA-seq基因芯片
Papillary thyroid carcinomaELF3ImmunohistochemistryRNA-sequencingGene chip
《医学信息》 2026 (10)
10-20,31,12
广西壮族自治区卫生健康委员会科研课题(编号:Z-A20220521)
评论